Found: 5
Select item for more details and to access through your institution.
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
- Published in:
- PLoS ONE, 2023, v. 18, n. 7, p. 1, doi. 10.1371/journal.pone.0288598
- By:
- Publication type:
- Article
Why sexual health clinics are important in the 2020s.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0125287
- By:
- Publication type:
- Article
Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens.
- Published in:
- International Journal of STD & AIDS, 2021, v. 32, n. 12, p. 1165, doi. 10.1177/09564624211027099
- By:
- Publication type:
- Article
Lymphogranuloma venereum: a rare and forgotten cause of rectal stricture formation.
- Published in:
- 2018
- By:
- Publication type:
- journal article